| Disease | angioedema |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 1 |
| PubMedID- 23972359 | The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-iv inhibitor, anagliptin. |
Page: 1